{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-210456","form_type":"8-K","ticker":"IOSP","cik":"0001054905","company_name":"INNOSPEC INC.","filed_at":"2022-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.811901+00:00","generated_at":"2026-06-24T04:48:15.781699+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Innospec Q2 2022 revenue up 32% to $467.6M; adjusted EPS $1.58 vs $1.30 last year","bullets":["GAAP EPS of $1.29 ($32.3M net income) versus $0.90 in Q2 2021.","Adjusted non-GAAP EPS of $1.58; revenue $467.6M, up 32% YoY.","EBITDA of $52.9M compared to $50.6M a year ago.","Cash used in operations $7.5M due to working capital increase; net cash $71.4M at quarter end.","Repurchased 18,700 shares for $1.8M; plans for further Performance Chemicals capacity expansion."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-210456","json":"https://secwatch.observer/filing/0001193125-22-210456.json","markdown":"https://secwatch.observer/filing/0001193125-22-210456.md","text":"https://secwatch.observer/filing/0001193125-22-210456.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054905/000119312522210456/0001193125-22-210456-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054905/000119312522210456/d361925d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T04:48:15.781699+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}